Apoplexy of Crooke cell tumour leading to the diagnosis of severe Cushing disease; a case report.


Journal

BMC endocrine disorders
ISSN: 1472-6823
Titre abrégé: BMC Endocr Disord
Pays: England
ID NLM: 101088676

Informations de publication

Date de publication:
01 May 2021
Historique:
received: 26 11 2020
accepted: 26 04 2021
entrez: 2 5 2021
pubmed: 3 5 2021
medline: 27 11 2021
Statut: epublish

Résumé

Patients with Crooke cell tumours present with features of Cushing syndrome or mass effect. There are few reports of patients with Crooke cell tumours presenting due to apoplexy. All of them had silent tumours. Patients with Cushing syndrome caused by Crooke cell tumours have not been reported to present with apoplexy. A 35-year-old female presented with sudden onset headache and visual loss for 1 week. She had secondary amenorrhoea for 10 years. There were features of Cushing syndrome including central obesity, multiple monomorphic acne, dorso-cervical and supraclavicular fat pads, hypertension, proximal weakness, pigmentation and refractory hypokalaemia. She was found to have markedly elevated serum cortisol, central hypothyroidism and hypogonadotropic hypogonadism. There was a mass in the sellar region (4.7 cm × 1.9 cm × 5.3 cm) suggestive of a pituitary tumour extending to the suprasellar region. Imaging showed evidence of bleeding and compression of the optic chiasm. She underwent urgent trans-sphenoidal excision of the tumour. Histology was compatible with a pituitary neuroendocrine tumour. There was margination of ACTH reactivity to the cell periphery and ring like positivity in most of the cells in the cytokeratin stain. Features were in favour of a Crooke cell tumour. After surgery she improved gradually and became eucortisolaemic. This is a unique presentation of an apoplexy of Crooke cell tumour causing Cushing syndrome. Delayed health seeking behaviour of this patient despite severe Cushing disease could have led to this presentation which has not been reported before.

Sections du résumé

BACKGROUND BACKGROUND
Patients with Crooke cell tumours present with features of Cushing syndrome or mass effect. There are few reports of patients with Crooke cell tumours presenting due to apoplexy. All of them had silent tumours. Patients with Cushing syndrome caused by Crooke cell tumours have not been reported to present with apoplexy.
CASE PRESENTATION METHODS
A 35-year-old female presented with sudden onset headache and visual loss for 1 week. She had secondary amenorrhoea for 10 years. There were features of Cushing syndrome including central obesity, multiple monomorphic acne, dorso-cervical and supraclavicular fat pads, hypertension, proximal weakness, pigmentation and refractory hypokalaemia. She was found to have markedly elevated serum cortisol, central hypothyroidism and hypogonadotropic hypogonadism. There was a mass in the sellar region (4.7 cm × 1.9 cm × 5.3 cm) suggestive of a pituitary tumour extending to the suprasellar region. Imaging showed evidence of bleeding and compression of the optic chiasm. She underwent urgent trans-sphenoidal excision of the tumour. Histology was compatible with a pituitary neuroendocrine tumour. There was margination of ACTH reactivity to the cell periphery and ring like positivity in most of the cells in the cytokeratin stain. Features were in favour of a Crooke cell tumour. After surgery she improved gradually and became eucortisolaemic.
CONCLUSIONS CONCLUSIONS
This is a unique presentation of an apoplexy of Crooke cell tumour causing Cushing syndrome. Delayed health seeking behaviour of this patient despite severe Cushing disease could have led to this presentation which has not been reported before.

Identifiants

pubmed: 33933049
doi: 10.1186/s12902-021-00761-2
pii: 10.1186/s12902-021-00761-2
pmc: PMC8088723
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

93

Références

Neurosurgery. 2015 May;76(5):616-22
pubmed: 25635886
J Clin Neurosci. 2012 Nov;19(11):1586-9
pubmed: 22658488
World Neurosurg. 2019 Feb;122:480-484
pubmed: 30465959
Endocr Pract. 2014 Dec;20(12):1274-80
pubmed: 25100377
Endocr Pathol. 2002 Fall;13(3):245-9
pubmed: 12446925
Clin Endocrinol (Oxf). 1999 Aug;51(2):181-8
pubmed: 10468988
AACE Clin Case Rep. 2018 Nov 01;5(2):e150-e153
pubmed: 31967022
World Neurosurg. 2018 Nov;119:197-200
pubmed: 30077745
Am J Surg Pathol. 2003 Oct;27(10):1330-6
pubmed: 14508394
Neurosurgery. 2005;56(1):65-72; discussion 72-3
pubmed: 15617587

Auteurs

Nipun Lakshitha de Silva (NL)

Diabetes and Endocrine Unit, National Hospital of Sri Lanka, Colombo 10, Sri Lanka. nipunlak@gmail.com.

Noel Somasundaram (N)

Diabetes and Endocrine Unit, National Hospital of Sri Lanka, Colombo 10, Sri Lanka.

Roshana Constantine (R)

Department of Histopathology, National Hospital of Sri Lanka, Colombo 10, Sri Lanka.

Himashi Kularatna (H)

Neurosurgical Unit, National Hospital of Sri Lanka, Colombo 10, Sri Lanka.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH